Literature DB >> 24145842

Post-ICU admission fluid balance and pediatric septic shock outcomes: a risk-stratified analysis.

Kamal Abulebda1, Natalie Z Cvijanovich, Neal J Thomas, Geoffrey L Allen, Nick Anas, Michael T Bigham, Mark Hall, Robert J Freishtat, Anita Sen, Keith Meyer, Paul A Checchia, Thomas P Shanley, Jeffrey Nowak, Michael Quasney, Scott L Weiss, Arun Chopra, Sharon Banschbach, Eileen Beckman, Christopher J Lindsell, Hector R Wong.   

Abstract

OBJECTIVE: Observed associations between fluid balance and septic shock outcomes are likely confounded by initial mortality risk. We conducted a risk-stratified analysis of the association between post-ICU admission fluid balance and pediatric septic shock outcomes.
DESIGN: Retrospective analysis of an ongoing multicenter pediatric septic shock clinical and biological database.
SETTING: Seventeen PICUs in the United States. PATIENTS: Three hundred and seventeen children with septic shock.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We stratified subjects into three mortality risk categories (low, intermediate, and high) using a validated biomarker-based stratification tool. Within each category, we assessed three fluid balance variables: total fluid intake/kg/d during the first 24 hours, percent positive fluid balance during the first 24 hours, and cumulative percent positive fluid balance up to 7 days. We used logistic regression to estimate the effect of fluid balance on the odds of 28-day mortality, and on complicated course, which we defined as either death within 28 days or persistence of two or more organ failures at 7 days. There were 40 deaths, and 91 subjects had a complicated course. Increased cumulative percent positive fluid balance was associated with mortality in the low-risk cohort (n = 204; odds ratio, 1.035; 95% CI, 1.004-1.066) but not in the intermediate- and high-risk cohorts. No other associations with mortality were observed. Fluid intake, percent positive fluid balance in the first 24 hours, and cumulative percent positive fluid balance were all associated with increased odds of a complicated course in the low-risk cohort but not in the intermediate- and high-risk cohorts.
CONCLUSIONS: When stratified for mortality risk, increased fluid intake and positive fluid balance after ICU admission are associated with worse outcomes in pediatric septic shock patients with a low initial mortality risk but not in patients at moderate or high mortality risk.

Entities:  

Mesh:

Year:  2014        PMID: 24145842      PMCID: PMC3947064          DOI: 10.1097/CCM.0b013e3182a64607

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  37 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum.

Authors:  Hector R Wong; Natalie Cvijanovich; Geoffrey L Allen; Richard Lin; Nick Anas; Keith Meyer; Robert J Freishtat; Marie Monaco; Kelli Odoms; Bhuvaneswari Sakthivel; Thomas P Shanley
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

3.  Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome.

Authors:  Hector R Wong; Thomas P Shanley; Bhuvaneswari Sakthivel; Natalie Cvijanovich; Richard Lin; Geoffrey L Allen; Neal J Thomas; Allan Doctor; Meena Kalyanaraman; Nancy M Tofil; Scott Penfil; Marie Monaco; Mary Ann Tagavilla; Kelli Odoms; Katherine Dunsmore; Michael Barnes; Bruce J Aronow
Journal:  Physiol Genomics       Date:  2007-03-20       Impact factor: 3.107

4.  ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation.

Authors:  Cláudio F de Oliveira; Débora S F de Oliveira; Adriana F C Gottschald; Juliana D G Moura; Graziela A Costa; Andréa C Ventura; José Carlos Fernandes; Flávio A C Vaz; Joseph A Carcillo; Emanuel P Rivers; Eduardo J Troster
Journal:  Intensive Care Med       Date:  2008-03-28       Impact factor: 17.440

5.  Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.

Authors:  Joe Brierley; Joseph A Carcillo; Karen Choong; Tim Cornell; Allan Decaen; Andreas Deymann; Allan Doctor; Alan Davis; John Duff; Marc-Andre Dugas; Alan Duncan; Barry Evans; Jonathan Feldman; Kathryn Felmet; Gene Fisher; Lorry Frankel; Howard Jeffries; Bruce Greenwald; Juan Gutierrez; Mark Hall; Yong Y Han; James Hanson; Jan Hazelzet; Lynn Hernan; Jane Kiff; Niranjan Kissoon; Alexander Kon; Jose Irazuzta; Jose Irazusta; John Lin; Angie Lorts; Michelle Mariscalco; Renuka Mehta; Simon Nadel; Trung Nguyen; Carol Nicholson; Mark Peters; Regina Okhuysen-Cawley; Tom Poulton; Monica Relves; Agustin Rodriguez; Ranna Rozenfeld; Eduardo Schnitzler; Tom Shanley; Saraswati Kache; Sara Skache; Peter Skippen; Adalberto Torres; Bettina von Dessauer; Jacki Weingarten; Timothy Yeh; Arno Zaritsky; Bonnie Stojadinovic; Jerry Zimmerman; Aaron Zuckerberg
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

6.  Role of early fluid resuscitation in pediatric septic shock.

Authors:  J A Carcillo; A L Davis; A Zaritsky
Journal:  JAMA       Date:  1991-09-04       Impact factor: 56.272

7.  Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.

Authors:  Hector R Wong; Natalie Cvijanovich; Derek S Wheeler; Michael T Bigham; Marie Monaco; Kelli Odoms; William L Macias; Mark D Williams
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

8.  Validating the genomic signature of pediatric septic shock.

Authors:  Natalie Cvijanovich; Thomas P Shanley; Richard Lin; Geoffrey L Allen; Neal J Thomas; Paul Checchia; Nick Anas; Robert J Freishtat; Marie Monaco; Kelli Odoms; Bhuvaneswari Sakthivel; Hector R Wong
Journal:  Physiol Genomics       Date:  2008-05-06       Impact factor: 3.107

9.  Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock.

Authors:  Thomas P Shanley; Natalie Cvijanovich; Richard Lin; Geoffrey L Allen; Neal J Thomas; Allan Doctor; Meena Kalyanaraman; Nancy M Tofil; Scott Penfil; Marie Monaco; Kelli Odoms; Michael Barnes; Bhuvaneswari Sakthivel; Bruce J Aronow; Hector R Wong
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

Review 10.  Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome.

Authors:  Yong Y Han; Joseph A Carcillo; Michelle A Dragotta; Debra M Bills; R Scott Watson; Mark E Westerman; Richard A Orr
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124

View more
  27 in total

1.  Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock.

Authors:  Matthew N Alder; Amy M Opoka; Patrick Lahni; David A Hildeman; Hector R Wong
Journal:  Crit Care Med       Date:  2017-04       Impact factor: 7.598

Review 2.  The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology.

Authors:  Matthew N Alder; Christopher J Lindsell; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2014-04-22       Impact factor: 5.091

Review 3.  Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis.

Authors:  Jonathan A Silversides; Emmet Major; Andrew J Ferguson; Emma E Mann; Daniel F McAuley; John C Marshall; Bronagh Blackwood; Eddy Fan
Journal:  Intensive Care Med       Date:  2016-10-12       Impact factor: 17.440

4.  Endotype Transitions During the Acute Phase of Pediatric Septic Shock Reflect Changing Risk and Treatment Response.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie C Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Riad Lutfi; Shira Gertz; Jocelyn R Grunwell; Christopher J Lindsell
Journal:  Crit Care Med       Date:  2018-03       Impact factor: 7.598

5.  Early fluid accumulation in children with shock and ICU mortality: a matched case-control study.

Authors:  Priya Bhaskar; Archana V Dhar; Marita Thompson; Raymond Quigley; Vinai Modem
Journal:  Intensive Care Med       Date:  2015-06-11       Impact factor: 17.440

Review 6.  Sepsis Biomarkers.

Authors:  Hector R Wong
Journal:  J Pediatr Intensive Care       Date:  2019-01-11

7.  Association Between Fluid Balance and Outcomes in Critically Ill Children: A Systematic Review and Meta-analysis.

Authors:  Rashid Alobaidi; Catherine Morgan; Rajit K Basu; Erin Stenson; Robin Featherstone; Sumit R Majumdar; Sean M Bagshaw
Journal:  JAMA Pediatr       Date:  2018-03-01       Impact factor: 16.193

8.  Developing a clinically feasible personalized medicine approach to pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Thomas P Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Raj S Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J Lindsell
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

9.  Acute Kidney Injury in a Child Receiving Vancomycin and Piperacillin/Tazobactam.

Authors:  Bethany W Ibach; Emilie D Henry; Peter N Johnson
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Mar-Apr

Review 10.  Sepsis in Pediatric Cardiac Intensive Care.

Authors:  Derek S Wheeler; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.